WaferGen Biosystems Inc Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125

13:40 EDT 1 Aug 2017 | BioPortfolio Reports

WaferGen Biosystems Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.


WaferGen Biosystems Inc WaferGen is a biotechnology Company which develops, manufactures and sells systems for genomic technology solutions for singlecell analysis and clinical research. The Company's ICELL8 SingleCell System platform isolates single cells and process specific cells for analysis, including Next Generation Sequencing NGS. The Company's SmartChip platform is used for profiling and validating molecular biomarkers, and also performs singleplex PCR for onestep target and preparation for clinical NGS. Its Apollo 324 system processes DNA and RNA from clinical samples to NGSready libraries. The company's technologies serve pharmaceutical and life science companies as well as clinical laboratories. WaferGen is the subsidiary of Takara Bio USA Holdings, Inc., and is headquartered in Fremont, California, the US.

WaferGen Biosystems Inc Key Recent Developments

Feb 15,2017: WaferGen Biosystems Reports Revenue Growth in Fourth Quarter of 2016
Dec 15,2016: WaferGen Biosystems Regains Compliance with Nasdaq Listing Requirements
Nov 08,2016: WaferGen Biosystems Reports Results for Third Quarter 2016
Oct 31,2016: WaferGen Biosystems Reports Strong Revenue Growth in Third Quarter of 2016
Aug 09,2016: WaferGen Biosystems Reports Results for Second Quarter 2016

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: WaferGen Biosystems Inc Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125


More From BioPortfolio on "WaferGen Biosystems Inc Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...